Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry (Revision: v3.3.3) was added to the page history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed from the footer.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRecord History now lists a new revision entry v3.3.2 and removes the previous v3.3.1.SummaryDifference0.1%

- Check40 days agoChange DetectedThe Record History now shows a new revision entry (v3.3.1) and the previous entry (v3.2.0) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the banner about government funding and NIH operating status from the Record History page. This does not affect study data, status, or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedVersion 2 (2021-10-12) updated the recruitment status for the study NCT04407988 in the record history.SummaryDifference0.1%

- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.2.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.